Health care consolidation under the Affordable Care Act / edited by Dominik Vogel.

Format:

Book

Contributor:

Vogel, Dominik, editor.

Series:

Health Care in Transition

Language:

English

Subjects (All):

United States. Patient Protection and Affordable Care Act.

United States.

Patient Protection and Affordable Care Act (United States).

Medical care, Cost of--United States.

Medical care, Cost of.

United States--Patient Protection and Affordable Care Act.

Physical Description:

1 online resource (282 pages) : illustrations

Place of Publication:

New York, New York : Snova, [2019]

Summary:

When the Affordable Care Act was just beginning to be implemented in 2013, the HHS secretary released a report stating the goal of Affordable Healthcare Act is to increase competition and transparency in the markets for individuals and small group insurance leading to higher quality, more affordable products. Fast forward 4 years later, what we are seeing is a decrease in competition and an increase in premium costs. This trend is concerning for all Americans and is discussed in this book.

Contents:

Intro

Contents

Preface

Chapter 1

Examining the Impact of Healthcare Consolidation(

Opening Statement of Hon. Gregg Harper, a Representative in Congress from the State of Mississippi

Prepared Statement of Hon. Gregg Harper

Opening Statement of Hon. Diana Degette, a Representative in Congress from the State of Colorado

Prepared Statement of Hon. Diana Degette

Opening Statement of Hon. Greg Walden, a Representative in Congress from the State of Oregon

Prepared Statement of Hon. Greg Walden

Opening Statement of Hon. Frank Pallone, Jr., a Representative in Congress from the State of New Jersey

Prepared Statement of Hon. Frank Pallone, Jr.

Statements of Martin Gaynor, Ph.D., E.J. Barone University Professor of Economics and Health Policy, Heinz College, Carnegie Mellon University

Leemore S. Dafny, Ph.D., Bruce V. Rauner Professor of Business Administration, Harvard Business School

And...

Statement of Martin Gaynor

Examining the Impact of Health Care Consolidation, Statement before the Committee on Energy and Commerce Oversight and Investigations Subcommittee, U.S. House of Representatives

Summary of Statement

Statement

1. My Background

2. Introduction

3. Consolidation

3.1. Hospitals

3.2. Physicians

3.3. Insurers

4. Evidence on the Impacts of Consolidation

4.1. Impacts on Prices

4.1.1. Hospitals

4.1.2. Physicians

4.1.3. Insurers

4.2. Impacts on Quality

4.2.1. Hospitals

4.2.2. Physicians

4.3. Impacts on Costs, Coordination, Quality

5. Policies to Make Health Care Markets Work

Bibliography

Statement of Leemore S. Dafny.

Testimony of Leemore S. Dafny, Ph.D., Bruce V. Rauner Professor of Business Administration Harvard Business School, Harvard John F. Kennedy School of Government, before the House Committee on Energy and Commerce Subcommittee on Oversight and Investig...

Introduction

I. Preface: Defining Consolidation and the Scope of the Healthcare Sector

II. The Facts: Where Consolidation Has Occurred, and What We Know About Its Effects

II.A. Horizontal Consolidation

II.A.1. Hospitals

II.A.2. Physicians

II.A.3. Health Insurers

II.B. Non-Horizontal Consolidation

II.B.1. "Cross-Market" Hospital Consolidation

II.B.2. Hospital-Physician Consolidation

III. The Reasons: Why Consolidation Is Occurring

IV. The Responses: Current Responses of the Private and Public Sectors to Consolidation

IV.A. Public Sector Responses

IV.A.1. Antitrust Enforcement

IV.A.2. State Agencies and Actions

IV.B. Private Sector Responses

V. Recommendations: What Else Could Be Done?

Statement of Kevin A. Schulman

Testimony, Kevin A. Schulman, MD, Professor of Medicine Duke University Durham, NC, Visiting Scholar Harvard Business School, Boston, MA, Committee on Energy and Commerce Subcommittee on Oversight and Investigations, February 14, 2018

Summary Points

Leading Change-A National Survey of Chief Innovation Officers in Health Systems

Abstract

Methods

Survey Development

Survey Sample

Survey Administration

Data Analysis

Results

Discussion

Acknowledgments

References

U.S. House of Representatives Committee on Energy and Commerce

I. Introduction

II. Witnesses

III. Background

A. Health Care Expenditures

B. Health Care Consolidation

i. Overview

ii. Hospital and Hospital-Physician Consolidation

iii. Insurer Consolidation.

C. Federal Trade Commission and Department of Justice

iv. Issues

v. Staff Contacts

Health Affairs Blog: Building Something Worth Building for All Patients

Editor's Note

Ownership Encourages Quality

The Relative Efficiency of ASCs

The Need for Better Data on Physician Owners of ASCs

Differing Attitudes toward the Provision of Health Care

Statement for the Record: The National Community Pharmacists Association (NCPA), United States House of Representatives Energy and Commerce Committee Subcommittee on Oversight and Investigations, Hearing: "Examining the Impact of Health Care Consolida...

Concentrated PBM Marketplace

Effects of PBM Consolidation on Consumers and Payers

PBM Industry Largely Unregulated

CVS Health -Aetna Inc. Merger and Its Potential Impact on Consumers

Conclusion

One Hundred Fifteenth Congress, Congress of the United States, House of Representatives, Committee on Energy and Commerce, March 13, 2018

Additional Questions for the Record the Honorable Earl "Buddy" Carter

Representative Yyvette Clarke

Health Care Industry Consolidation, Responses to Questions from the Committee on Energy and Commerce Oversight and Investigations Subcommittee, U.S. House of Representatives, by Martin Gaynor, E.J. Barone University Professor of Economics and Health P...

1. Introduction

2. Question from the Honorable Earl "Buddy" Carter

3. Question from Representative Yvette Clarke

Attachment-Additional Questions for the Record

The Honorable Michael C. Burgess

The Honorable Yyvette Clarke

One Hundred Fifteenth Congress, Congress of the United States, House of Representatives, Committee on Energy and Commerce, March 13, 2018.

Additional Questions for the Record

The Honorable Yvvettc Clarke

Additional Question for the Record, Kevin A. Schulman, MD, Professor of Medicine Duke University Durham, NC, Visiting Scholar Harvard Business School, Boston, MA, Committee on Energy and Commerce Subcommittee on Oversight and Investigations, March 21,...

Questions from the Honorable Yvette Clarke

Chapter 2

Examining the Effectiveness of the Individual Mandate under the Affordable Care Act

Chairman Buchanan Announces Hearing on Examining the Effectivenessof the Individual Mandate

Under the Affordable Care Act

Details for Submission of Written Comments

Formatting Requirements

Statement of John R. Graham, Senior Fellow at the National Center for Policy Analysis

Statement of Thomas Miller, Resident Fellow, American Enterprise Institute

Statement before the House Committee on Ways and Means Subcommittee on Oversight

Rearranging Increased Coverage Costs

Weak Enforcement

Weak Compliance

Still the Most Unpopular Part of the ACA

Reciprocal Floors and Ceilings Limit the Individual Mandate

Impact on Insurance Coverage Expansion?

Future Unknowns

Alternatives

Statement of John E. Mcdonough, DrPH, MPA, Professor of Practice, Department of Health Policy and Management, Harvard Th Chan School of Public Health

Statement on "The Individual Mandate under the Affordable Care Act"

Submitted to the House Ways and Means Committee Subcommittee on Oversight

The Rationale for Full Consumer Participation

Alternative Approaches to Encouraging Continuous Coverage and Broad Participation in the Individual Health Insurance Market

Index

Blank Page.

Notes:

Includes index.

Description based on print version record.

ISBN:

1-5361-6871-8

OCLC:

1134076028